FDA Inspection 1341660 — Intermountain Health Saint Joseph Hospital
The FDA completed an inspection of Intermountain Health Saint Joseph Hospital on Oct 9, 2026 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 9, 2026
- Fiscal Year
- 2027
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Denver, CO (United States)